Arkadios Wealth Advisors

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1800798 ATLANTA, GA

Position in VRTX

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$1,645,052

-$152,519 QoQ

Shares Held

3,684

-7.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Arkadios Wealth Advisors holds $12,704,540 across 13 Biotechnology names. VRTX ranks #4 (12.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	4,435	$3,426,657
2	JAZZ	Jazz Pharmaceuticals plc	11,960	$2,261,037
3	TYRA	Tyra Biosciences, Inc.	47,567	$1,821,816
4	VRTX	Vertex Pharmaceuticals Inc / Ma This page	3,684	$1,645,052
5	HALO	Halozyme Therapeutics, Inc.	19,622	$1,268,169
6	MRNA	Moderna, Inc.	17,857	$907,135
7	EXEL	Exelixis, Inc.	11,098	$475,992
8	CRSP	CRISPR Therapeutics AG	9,416	$447,918

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,645,052	3,684	-7.1%	Shares	Sole	2026-05-18
2025-12-31	$1,797,571	3,965	+69.9%	Shares	Sole	2026-02-13
2025-09-30	$914,086	2,334	+8.5%	Shares	Sole	2025-10-29
2025-06-30	$958,069	2,152	+47.9%	Shares	Sole	2025-08-04
2025-03-31	$705,412	1,455	+34.6%	Shares	Sole	2025-05-08
2024-12-31	$435,318	1,081	+61.1%	Shares	Sole	2025-01-15
2024-09-30	$312,068	671	+454.5%	Shares	Sole	2024-10-24
2021-09-30	$21,948	121	+21.0%	Shares	Sole	2021-10-19
2021-06-30	$20,163	100	+2400.0%	Shares	Sole	2021-07-28
2020-03-31	$951	4	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.